On October 25th, we visited Stanford, California, for a State of the Science Summit on Ovarian Cancer and Soft Tissue Sarcoma. At the meeting, faculty from Stanford Medicine discussed advances made in the treatment landscapes, touching on available modalities, such as immunotherapy, antibody drug conjugates, and PARP inhibitors.

Podcasts

that provides oncology professionals with the resources and information they need to provide the best patient care. Segments cover every angle of oncology practice, from new technology to treatment advances to important regulatory decisions. New episodes with exclusive interviews with leading oncology experts are released on Mondays and Thursdays. 

State of the Science Summits

We headed to Stanford, California, for a State of the Science Summit on Ovarian Cancer and Soft Tissue Sarcoma, which focused on recent advances made in the treatment landscapes.

Exploring Strides Made in Ovarian Cancer & STS in Stanford